<h2>Question</h2>
<div class='specification'>
<p>The structures of oseltamivir (Tamiflu) and zanamivir (Relenza) are given in section 37 of the&nbsp;data booklet.</p>
</div>

<div class='question' style='padding-left: 20px; padding-right: 20px;'>
<p>Compare and contrast the structures of oseltamivir and zanamivir, stating the&nbsp;names of functional groups.</p>
<p><img src="data:image/png;base64,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" /></p>
<div class='marks'>[2]</div>
<div class='question_part_label'>a.i.</div>
</div>
<div class='question' style='padding-left: 20px; padding-right: 20px;'>
<p>Deduce the wavenumber of one absorbance seen in the IR spectrum of only one&nbsp;of the compounds, using section 26 of the data booklet.</p>
<div class='marks'>[1]</div>
<div class='question_part_label'>a.ii.</div>
</div>
<div class='question' style='padding-left: 20px; padding-right: 20px;'>
<p>Suggest <strong>one</strong> ethical consideration faced by medical researchers when&nbsp;developing medications.</p>
<div class='marks'>[1]</div>
<div class='question_part_label'>b.</div>
</div>
<h2 style='margin-top: 1em'>Markscheme</h2>
<div class='question' style='padding-left: 20px;'>
<p><em>One similarity:</em></p>
<p>both contain amido &laquo;group&raquo;</p>
<p><em>One difference:</em></p>
<p>oseltamivir contains ester &laquo;group&raquo; <em><strong>AND</strong></em> zanamivir does not<br /><em><strong>OR</strong></em><br />oseltamivir contains amino &laquo;group&raquo; <em><strong>AND</strong></em> zanamivir does not &laquo;but contains a&nbsp;guanidino group&raquo;<br /><em><strong>OR</strong></em><br />zanamivir contains carboxyl &laquo;group&raquo; <em><strong>AND</strong></em> oseltamivir does not<br /><em><strong>OR</strong></em><br />zanamivir contains &laquo;several&raquo; hydroxyl &laquo;groups&raquo; <em><strong>AND</strong></em> oseltamivir does not<br /><em><strong>OR</strong></em><br />oseltamivir contains ester &laquo;group&raquo; <em><strong>AND</strong></em> zanamivir contains carboxyl &laquo;group&raquo;<br /><em><strong>OR</strong></em><br />oseltamivir contains ester &laquo;group&raquo; <em><strong>AND</strong></em> zanamivir contains &laquo;several&raquo; hydroxyl&nbsp;&laquo;groups&raquo;</p>
<p>&nbsp;</p>
<p><em>Accept &ldquo;both contain ether &laquo;group&raquo;&rdquo; <strong>OR</strong> &ldquo;both contain alkene/alkenyl &laquo;group&raquo;&rdquo; <strong>OR</strong> &ldquo;both contain carbonyl &laquo;group&raquo;&rdquo; <strong>OR</strong> &ldquo;both contain amino/amine&nbsp;&laquo;group&raquo;&rdquo;. Latter cannot be given in&nbsp;combination with second difference&nbsp;alternative with respect to amino group.</em></p>
<p><em>Accept &ldquo;amide/carboxamide/carbamoyl&rdquo;&nbsp;for &ldquo;amido&rdquo;.</em></p>
<p><em>Accept &ldquo;amine&rdquo; for &ldquo;amino&rdquo;.</em></p>
<p><em>Accept &ldquo;carboxylic acid&rdquo; for &ldquo;carboxyl&rdquo;.</em></p>
<p><em>Accept &ldquo;hydroxy/alcohol&rdquo; for &ldquo;hydroxyl&rdquo;, but not &ldquo;hydroxide&rdquo;.</em></p>
<p><strong><em>[2 marks]</em></strong></p>
<div class='question_part_label'>a.i.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p>1050&ndash;1410<br /><em><strong>OR</strong></em><br />1620&ndash;1680<br /><em><strong>OR</strong></em><br />1700&ndash;1750<br /><em><strong>OR</strong></em><br />2500&ndash;3000<br /><em><strong>OR</strong></em><br />3200&ndash;3600<br /><em><strong>OR</strong></em><br />2850&ndash;3090<br /><em><strong>OR</strong></em><br />3300&ndash;3500 &laquo;cm<sup>&ndash;1</sup>&raquo;</p>
<p><em><strong>[1 mark]</strong></em></p>
<div class='question_part_label'>a.ii.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p>&laquo;negative&raquo; side-effects of medication on patient/volunteers<br /><em><strong>OR</strong></em><br />effects on environment &laquo;from all materials used and produced&raquo;<br /><em><strong>OR</strong></em><br />potential for abuse<br /><em><strong>OR</strong></em><br />drugs may be developed that are contrary to some religious doctrines<br /><em><strong>OR</strong></em><br />animal testing<br /><em><strong>OR</strong></em><br />risk to benefit ratio<br /><em><strong>OR</strong></em><br />appropriate consent of patient volunteers</p>
<p><em><strong>[1 mark]</strong></em></p>
<div class='question_part_label'>b.</div>
</div>
